ScandiBio Therapeutics is a biotechnology company founded by researchers from the KTH Royal Institute of Technology, Karolinska Institutet and Sahlgrenska Academy in Sweden and Kings College, UK. The science originates from research conducted at the Science for Life Laboratory in Stockholm (Dr Adil Mardinoglu and Professor Mathias Uhlen) together with researchers at the Sahlgrenska Academy in Göteborg (Professor Jan Boren).